Skip to main content
Erschienen in: Clinical & Experimental Metastasis 6-7/2017

06.09.2017 | Commentary

Historical perspectives on the biology of brain metastasis

verfasst von: J. Dawn Waters, Reid Hoshide, Rahul Jandial

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 6-7/2017

Einloggen, um Zugang zu erhalten

Excerpt

Curing cancer has been a national emphasis since Richard Nixon declared “war on cancer” upon signing the National Cancer Act into law in 1971. Despite tremendous advances in prevention, diagnosis, and treatment, cancer remains the second most frequent cause of death in the United States and a leading cause of death worldwide [1]. The most lethal event in the progression of this disease is the metastatic invasion of cancer cells throughout the body, leading to 90% of cancer deaths [2]. Since cancers are often metastatic at the time of diagnosis, prevention and early detection are an incomplete solution. Even though patients within the United States and other developed countries are surviving longer with improved therapies for systemic cancer spread, metastases to the brain remains a singular challenge [2, 3]. …
Literatur
1.
4.
Zurück zum Zitat Barnholtz-Sloan JS et al (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14):2865–2872CrossRefPubMed Barnholtz-Sloan JS et al (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14):2865–2872CrossRefPubMed
5.
Zurück zum Zitat Sperduto PW et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30(4):419–425CrossRefPubMed Sperduto PW et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30(4):419–425CrossRefPubMed
6.
Zurück zum Zitat Patel SH et al (2012) ACR Appropriateness Criteria(R) follow-up and retreatment of brain metastases. Am J Clin Oncol 35(3):302–306CrossRefPubMed Patel SH et al (2012) ACR Appropriateness Criteria(R) follow-up and retreatment of brain metastases. Am J Clin Oncol 35(3):302–306CrossRefPubMed
8.
Zurück zum Zitat Paget S (1889) The distribution of secondary growths in cancer of the breast. The Lancet 133(3421):571–573CrossRef Paget S (1889) The distribution of secondary growths in cancer of the breast. The Lancet 133(3421):571–573CrossRef
9.
Zurück zum Zitat Dell H (2006) Milestones 1: observations from a ploughman. Nat Rev Cancer 6:S7CrossRef Dell H (2006) Milestones 1: observations from a ploughman. Nat Rev Cancer 6:S7CrossRef
10.
Zurück zum Zitat Ewing J (1928) Neoplastic diseases. A treatise on tumors. Am J Med Sci 176(2):278CrossRef Ewing J (1928) Neoplastic diseases. A treatise on tumors. Am J Med Sci 176(2):278CrossRef
11.
Zurück zum Zitat Hart IR, Fidler IJ (1980) Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 40(7):2281–2287PubMed Hart IR, Fidler IJ (1980) Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 40(7):2281–2287PubMed
12.
Zurück zum Zitat Sugarbaker ED (1952) The organ selectivity of experimentally induced metastases in rats. Cancer 5(3):606–612CrossRefPubMed Sugarbaker ED (1952) The organ selectivity of experimentally induced metastases in rats. Cancer 5(3):606–612CrossRefPubMed
13.
Zurück zum Zitat Fisher B, Fisher ER (1967) The organ distribution of disseminated 51 Cr-labeled tumor cells. Cancer Res 27(2):412–420PubMed Fisher B, Fisher ER (1967) The organ distribution of disseminated 51 Cr-labeled tumor cells. Cancer Res 27(2):412–420PubMed
14.
Zurück zum Zitat Fidler IJ (1973) Selection of successive tumour lines for metastasis. Nature 242(118):148–149 Fidler IJ (1973) Selection of successive tumour lines for metastasis. Nature 242(118):148–149
15.
Zurück zum Zitat Fidler IJ, Kripke ML (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197(4306):893–895CrossRefPubMed Fidler IJ, Kripke ML (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197(4306):893–895CrossRefPubMed
17.
Zurück zum Zitat Schackert G, Fidler IJ (1988) Development of in vivo models for studies of brain metastasis. Int J Cancer 41(4):589–594CrossRefPubMed Schackert G, Fidler IJ (1988) Development of in vivo models for studies of brain metastasis. Int J Cancer 41(4):589–594CrossRefPubMed
18.
Zurück zum Zitat Yoneda T et al (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16(8):1486–1495CrossRefPubMed Yoneda T et al (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16(8):1486–1495CrossRefPubMed
19.
21.
Zurück zum Zitat Eichler AF et al (2011) The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol 8(6):344–356PubMedPubMedCentral Eichler AF et al (2011) The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol 8(6):344–356PubMedPubMedCentral
Metadaten
Titel
Historical perspectives on the biology of brain metastasis
verfasst von
J. Dawn Waters
Reid Hoshide
Rahul Jandial
Publikationsdatum
06.09.2017
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 6-7/2017
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-017-9859-5

Weitere Artikel der Ausgabe 6-7/2017

Clinical & Experimental Metastasis 6-7/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.